coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Miles Platting Newton Heath & Moston PCN, Manchester (LAD) · Health Inequalities Profile

    PCN U13098 · NHS Greater Manchester Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    46,051

    Registered population

    62.6% aged 18–64

    13.2%

    Aged 65+

    ICB 14.9% · England 17.9%

    34.1%

    Ethnic minority (non-White)

    8.8% Asian · England 9.6%

    77.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~33,106

    Core20 residents (est.)

    Resident basis; registered basis ~36,819 · see page 3

    6,352

    Hypertension register

    +9.42% in 3 yrs · England +5.60%

    777

    SMI register

    8.2% of Manchester (LAD)'s

    1,360

    COPD register

    Reviews +3.38% in 3 yrs

    Forecast to 2030

    7,856

    Hypertension patients, 2030

    +1,504 on today

    81.9%

    QRISK ≥20% on statins, 2030

    +6.80pp over 3 yrs

    4.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    832
    Asthma reviews leave 832 patients unreviewed.

    Across 2,453 asthma patients, 66.1% had a review (Manchester (LAD) 67.0%), while prescribing is 2,201 rate per 1,000 aged 5-19 (England 1,488 rate).

    75.3%
    Pre-school MMR2 and booster coverage trail targets.

    Age-5 coverage is 75.3% for MMR2 (13.7 pp below MMR1 at 89.0%) and 69.9% for the 4-in-1 booster, below the 95.0% target.

    +32.6%
    Breast screening growth outpaces England.

    Three-year breast screening coverage rose +32.6% (England +8.4%), though current coverage at 61.2% still trails England (69.9%) and the ICB (68.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Children comprise 24.3% of registered patients, alongside an 18.0% Black resident population

    Across 46,051 registered patients, children aged 0-17 represent 24.3% (11,170 patients), exceeding Manchester (LAD) (21.4%), NHS Greater Manchester Integrated Care Board (21.8%), and England (19.6%). Patients aged 65+ form 13.2% (6,058 patients), above Manchester (LAD) (9.6%) but below the ICB (14.9%) and England (17.9%). Local Census usual residents include 18.0% Black, African, Caribbean, or Black British (LAD 11.9%, ICB 4.7%, England 4.2%) and 8.8% Asian (LAD 20.9%, ICB 13.6%, England 9.6%). These figures reflect resident Census geography rather than confirmed registered-patient ethnicity.

    Age profile

    0–1724.3%
    18–6462.6%
    65+13.2%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White65.9%
    Black18.0%
    Asian8.8%
    Mixed4.7%
    Other2.6%

    Older people · falls rows are Manchester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Manchester LA)2,3572,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)54.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Manchester LA)1,2811,0219552024/25
    Falls deaths, all ages, per 100,000 (Manchester LA)26.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 77.6% across the registered PCN population

    Core20 cohort (IMD quintile 1) comprises 77.6% of registered patients at PCN level, exceeding Manchester (LAD) (59.8%), NHS Greater Manchester Integrated Care Board (40.7%), and England (21.0%).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Mp Victoria Mill100.0% · 3,968 patients
    Droylsden Rd94.6% · 5,706 patients
    Whitley Road93.2% · 5,705 patients
    Newton Heath89.4% · 7,382 patients
    Simpson Medical87.8% · 4,629 patients
    St George's81.3% · 5,900 patients
    Hazeldene38.6% · 3,529 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    777

    SMI register

    1.68% recorded prevalence

    453

    Learning disability register

    0.98% recorded prevalence

    18

    Care homes, 601 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Manchester (LAD), Census 2021

    Recorded severe mental illness prevalence is 1.7% (777 patients) and learning disability is 1.0% (453 patients), exceeding Manchester (LAD) (1.3% and 0.7%), NHS Greater Manchester Integrated Care Board (1.1% and 0.6%), and England (1.0% and 0.6%). The PCN catchment contains 18 care homes with 601 beds, though capacity does not establish registered resident numbers. Higher recorded prevalence may reflect local morbidity patterns or proactive diagnosis, testable by clinical register audit.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.7% (England 1.0%). Recorded blood pressure checks match England at 83.4%. Annual BMI checks reach 79.1% (England 82.1%), rising +0.6 pp over 2023 to 2025 (England +5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,352

    Hypertension register

    +9.42%

    Register growth, 3 yrs

    Manchester (LAD) +4.49% · England +5.60%

    +3.23pp

    BP control, under 80

    ≤140/90 · −1.08pp aged 80+

    +1,504

    More patients by 2030

    Forecast 7,856 (16.43%)

    Hypertension case-finding and control

    Hypertension prevalence is 13.7% (6,352 patients), below England (15.2%) and NHS Greater Manchester Integrated Care Board (14.4%) but above Manchester (LAD) (10.5%). Recent blood pressure monitoring reached 90.0% (England 90.0%). Overall treatment to target was 70.8% (England 70.3%, NHS Greater Manchester Integrated Care Board 71.4%). Blood pressure control in patients aged under 80 was 68.9% (England 67.8%). However, control for patients aged 80 and over was 80.6% (England 81.2%), falling 1.3% over 2023 to 2025 while England rose +2.2% and NHS Greater Manchester Integrated Care Board rose +2.7%. Lagging blood pressure control among older patients could reflect adherence or recall gaps, which practice audits could test.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 65.9%, above England (63.6%) but below Manchester (LAD) (70.5%). Statin coverage in diabetes without CVD is 75.3%, above England (73.2%) and below Manchester (LAD) (79.8%). Lower uptake than the borough could reflect prescribing variation, which practice audits could test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202688,871£1.80£1.94£1.86£159,968
    Cardiovascular (all), 2025124,088£2.42£3.15£3.33£300,293

    In 2026, the PCN prescribed 88,871 lipid-regulating items at £1.80 per item, below Manchester (LAD) (£2.21), NHS Greater Manchester Integrated Care Board (£1.94), and England (£1.86). This represents £5,332 less than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +9.74%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.05%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 5.7% (England 6.6%, Manchester (LAD) 5.8%), while asthma management prescribing reaches 2,201 rate per 1,000 aged 5-19 (England 1,488 rate). With a 66.1% review rate (Manchester (LAD) 67.0%), an estimated 832 asthma patients remain unreviewed across 2,453 registered. COPD prevalence is 2.9% (England 1.9%), rising +14.6% over 2023 to 2025 (England +2.6%), with 75.3% reviewed (England 76.4%). Elevated paediatric prescribing could reflect acute reliever reliance, which prescribing audits could test.

    Cancer register and children's immunisation

    Cancer prevalence is 3.0% (1,364 patients), below England (3.8%) and above Manchester (LAD) (2.2%). In Q1 2025/26, 6-in-1 coverage at 24 months reached 92.0% (England 92.2%). At age 5, MMR dose 2 coverage was 75.3% (England 82.8%), trailing MMR dose 1 (89.0%) by 13.7 pp. The 4-in-1 booster reached 69.9% (England 80.9%), below the 95.0% target by 25.1 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.4%

    England 91.0%

    6-in-1 complete primary course at 24 months92.0%

    England 92.2%

    MMR dose 1 at 24 months87.5%

    England 88.3%

    MMR dose 2 at age 575.3%

    England 82.8%

    4-in-1 pre-school booster at age 569.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of cancers with a known stage in NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (6,491 of 11,679 cases), in line with England (55.3%) but below the 75.0% national ambition by 2028 by 19.4 pp. Staged cases represented 70.8% of all 16,492 registered cancers (England 67.0%). Closing this gap requires an estimated 2,268.2 additional early-stage diagnoses annually across the ICB. At PCN level, cervical screening coverage in women aged 25 to 49 is 61.1%, trailing England (66.8%) and the ICB (65.9%), although above Manchester (LAD) (57.2%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Manchester University NHS Foundation Trust achieved 72.8% on the 62-day cancer referral to treatment standard (385 of 528.5 pathways), below the 85.0% standard by 12.2 pp. This trailed Northern Care Alliance NHS Foundation Trust (78.6%), Tameside and Glossop Integrated Care NHS Foundation Trust (76.8%), and NHS Greater Manchester Integrated Care Board (75.7%), but exceeded England (71.2%). On the 28-day faster diagnosis standard, the trust reached 80.1% (4,706 of 5,878 pathways), exceeding the 75.0% standard by 5.1 pp, ahead of the ICB (79.5%) and England (79.3%), though behind Tameside and Glossop (82.5%).

    Pathways within standard (%)ManchesterNorthern Care AllianceTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2082.4879.5379.32
    31-day treatment (96%)92.5494.5496.2596.4992.50
    62-day referral to treatment (85%)72.8578.6576.7775.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceTameside and Glossop Integrated CareEngland
    MRI11.685.090.0021.40
    CT14.664.100.189.92
    Echocardiography4.9131.480.0028.48
    Colonoscopy4.5140.041.5130.83
    Gastroscopy29.3536.485.4529.02
    All 15 DM01 tests8.9815.710.8023.14
    Community services activityManchester residentsGreater Manchester ICB
    Care contacts96,995573,310
    Referrals20,27094,470
    Patients with a contact31,040183,535

    Community services (residents of Manchester), Jun 2026 (provisional). In June 2026 (provisional), community health service contacts for Manchester borough residents totaled 96,995 across all ages. Adults aged 65 and over accounted for 42,015 of these contacts, representing 43.3% of all community service activity for borough residents. These figures describe local authority resident activity rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 27.1 pp and good experience spans 19.8 pp across practices

    In 2025/26, overall QOF achievement ranged from 75.6% at Newton Heath Medical Centre to 92.7% at Simpson Medical Practice (England 92.5%). Vaccination and immunisation achievement spanned 27.0 pp across captured practices, from 15.6% at Mp Victoria Mill to 42.7% at Simpson Medical Practice (England 55.2%). Hazeldene Medical Centre achieved 99.0% on the clinical domain.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Hazeldene7238.689.3%87.7%91.8%
    Mp Victoria Mill109100.076.5%80.3%91.5%
    Whitley Road11793.274.1%75.6%86.4%
    Simpson Medical10187.862.2%75.3%82.2%
    St George's9381.370.5%69.4%81.3%
    Newton Heath9089.478.9%73.6%80.5%
    Droylsden Rd11094.662.7%83.2%72.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNManchester (LAD)AssetPCNManchester (LAD)
    Care homes (catchment)18 (601 beds)n/aSchools (catchment)63n/a
    Children's centres434Places of worship41289
    Libraries216Homelessness support (VCS)n/a1
    Primary schools (LA maintained)1368Primary academies850
    Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing recall

    Asthma reviews cover 66.1% of 2,453 register patients (Manchester (LAD) 67.0%, England 65.7%), leaving 832 patients without a recorded 12-month review. For discussion: run a single-template asthma recall combining annual review with inhaler prescribing checks, offering after-school slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster catch-up

    In Q1 2025/26, age-5 MMR2 is 75.3% (England 82.8%), 13.7 pp below MMR1 (89.0%), and 4-in-1 is 69.9% (England 80.9%), 25.1 pp below the 95.0% target. For discussion: audit age-5 cohorts missing MMR2 or 4-in-1 boosters and test flexible catch-up clinics. Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Hypertension case-finding and older-patient recall

    Recorded hypertension is 13.7% (6,352 of 46,051 patients; Manchester (LAD) 10.5%, England 15.2%), a modelled gap of -1,511 to +661 patients; 80+ BP control fell 1.3% (England +2.2%). For discussion: search records for uncoded raised BP readings and run structured recall for patients aged 80+ above target. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric appointment capacity review (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Core20 targeted outreach review (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall review (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older hypertension recall review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage capacity review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR2 and booster catch-up (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Hypertension case-finding and older-patient recall (p12)Hypertension register · Hypertension: QOF prevalence · Registered populationCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15